UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes

Clinical pharmacology and therapeutics, 2018-04, Vol.103 (4), p.712-721

2018

Volltextzugriff (PDF)

1226-P: A Rapid Rate of Kidney Function Decline Is Associated with Increased Risk of Heart Failure in Patients with Type 2 Diabetes—Results from ACCORD Study

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics

Cardiovascular diabetology, 2020-11, Vol.19 (1), p.190-190, Article 190

2020

Volltextzugriff (PDF)

Interleukin-6 ＂Trans-Signaling＂ and Ischemic Vascular Disease: The Important Role of Soluble gp130

Mediators of Inflammation, 2017-01, Vol.2017, p.1396398-6

2017

Volltextzugriff (PDF)

Deep-learning-based natural-language-processing models to identify cardiovascular disease hospitalisations of patients with diabetes from routine visits’ text

Scientific reports, 2023-11, Vol.13 (1), p.19132-19132, Article 19132

2023

Volltextzugriff (PDF)

Pharmacogenetics of Cardiovascular Prevention in Diabetes: From Precision Medicine to Identification of Novel Targets

Journal of personalized medicine, 2022-08, Vol.12 (9), p.1402

2022

Volltextzugriff (PDF)

In hospital risk factors for acute kidney injury and its burden in patients with Sars-Cov-2 infection: a longitudinal multinational study

Scientific reports, 2022-03, Vol.12 (1), p.3474-3474, Article 3474

2022

Volltextzugriff (PDF)

Performance assessment across different care settings of a heart failure hospitalisation risk-score for type 2 diabetes using administrative claims

Scientific reports, 2022-05, Vol.12 (1), p.7762-7762, Article 7762

2022

Volltextzugriff (PDF)

Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus

Cardiovascular diabetology, 2023-08, Vol.22 (1), p.204-204, Article 204

2023

Volltextzugriff (PDF)

Heart Failure Burden in Diabetes: Can Fenofibrate Provide Additional Hope?

Diabetes care, 2022-07, Vol.45 (7), p.1500-1502

Morieri, Mario Luca

2022

Volltextzugriff (PDF)

Association of Hypomorphic P2X7 Receptor Genotype With Age

Frontiers in molecular neuroscience, 2020-02, Vol.13, p.8-8

2020

Volltextzugriff (PDF)

Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation

BMC infectious diseases, 2018-01, Vol.18 (1), p.10-10, Article 10

2018

Volltextzugriff (PDF)

Correction to: Physicians' misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes

Cardiovascular diabetology, 2022-05, Vol.21 (1), p.73-73, Article 73

2022

Volltextzugriff (PDF)

Rapid kidney function decline and increased risk of heart failure in patients with type 2 diabetes: findings from the ACCORD cohort

Cardiovascular diabetology, 2023-06, Vol.22 (1), p.1-12

2023

Volltextzugriff (PDF)

Deciphering dementia in the cardiometabolic continuum

European heart journal, 2023-02, Vol.44 (7), p.583-585

2023

Volltextzugriff (PDF)

Editorial on “Genetics And Metabolic Diseases” Special Issue

Advanced biology, 2023-12, Vol.7 (12), p.e2300464-n/a

2023

Volltextzugriff (PDF)

The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast Italy

Diabetes care, 2021-01, Vol.44 (1), p.e18-e21

2021

Volltextzugriff (PDF)

The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes

Diabetes care, 2022-10, Vol.45 (10), p.2439-2444

2022

Volltextzugriff (PDF)

Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells

Diabetologia, 2023-12, Vol.66 (12), p.2346-2355

2023

Volltextzugriff (PDF)

Impact of MASLD and MetALD on clinical outcomes: A meta‐analysis of preliminary evidence

Liver international, 2024-08, Vol.44 (8), p.1762-1767

2024

Volltextzugriff (PDF)

Comparative effectiveness of dapagliflozin vs DPP‐4 inhibitors on a composite endpoint of HbA1c, body weight and blood pressure reduction in the real world

Diabetes/metabolism research and reviews, 2021-01, Vol.37 (1), p.e3353-n/a

2021

Volltextzugriff (PDF)

41-OR: ADA President's Select Abstract: The Beneficial Effect of Fenofibrate on Diabetic Retinopathy Is Influenced by PPARA Genetic Variability and Is Mediated by an Increase in FGF21 Levels

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

The Elusive Nature of ABCC8-related Maturity-Onset Diabetes of the Young (ABCC8-MODY). A Review of the Literature and Case Discussion

Current diabetes reports, 2024-09, Vol.24 (9), p.197-206

2024

Volltextzugriff (PDF)

Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history

The lancet. Diabetes & endocrinology, 2022-12, Vol.10 (12), p.882-889

2022

Volltextzugriff (PDF)

Insufficient Evidence for Interaction Between Haptoglobin Phenotypes and Intensive Glycemic Control on Cardiovascular Outcomes

Journal of the American College of Cardiology, 2020-06, Vol.75 (23), p.2995-2996

2020

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(57)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes

1226-P: A Rapid Rate of Kidney Function Decline Is Associated with Increased Risk of Heart Failure in Patients with Type 2 Diabetes—Results from ACCORD Study

Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics

Interleukin-6 ＂Trans-Signaling＂ and Ischemic Vascular Disease: The Important Role of Soluble gp130

Deep-learning-based natural-language-processing models to identify cardiovascular disease hospitalisations of patients with diabetes from routine visits’ text

Pharmacogenetics of Cardiovascular Prevention in Diabetes: From Precision Medicine to Identification of Novel Targets

In hospital risk factors for acute kidney injury and its burden in patients with Sars-Cov-2 infection: a longitudinal multinational study

Performance assessment across different care settings of a heart failure hospitalisation risk-score for type 2 diabetes using administrative claims

Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus

Heart Failure Burden in Diabetes: Can Fenofibrate Provide Additional Hope?

Association of Hypomorphic P2X7 Receptor Genotype With Age

Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation

Correction to: Physicians' misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes

Rapid kidney function decline and increased risk of heart failure in patients with type 2 diabetes: findings from the ACCORD cohort

Deciphering dementia in the cardiometabolic continuum

Editorial on “Genetics And Metabolic Diseases” Special Issue

The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast Italy

The Fast-Glycator Phenotype, Skin Advanced Glycation End Products, and Complication Burden Among People With Type 1 Diabetes

Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells

Impact of MASLD and MetALD on clinical outcomes: A meta‐analysis of preliminary evidence

Comparative effectiveness of dapagliflozin vs DPP‐4 inhibitors on a composite endpoint of HbA1c, body weight and blood pressure reduction in the real world

41-OR: ADA President's Select Abstract: The Beneficial Effect of Fenofibrate on Diabetic Retinopathy Is Influenced by PPARA Genetic Variability and Is Mediated by an Increase in FGF21 Levels

The Elusive Nature of ABCC8-related Maturity-Onset Diabetes of the Young (ABCC8-MODY). A Review of the Literature and Case Discussion

Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history

Insufficient Evidence for Interaction Between Haptoglobin Phenotypes and Intensive Glycemic Control on Cardiovascular Outcomes

Aktive Filter

Suchergebnisse filtern